*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Pharmacokinetic and Toxicological Studies of Liposomal Amphotericin B Eye Drops on the Rabbit Eye

Author: HUSNUN AMALIA, ARI ESTUNINGTYAS, RAHMAWATI RIDWAN, RATNA SITOMPUL, ROBIATUL ADAWIYAH, HANS-JOACHIM FREISLEBEN
Abstract: Keratomycosis is a fungal infection of the cornea in tropical areas and the cause of corneal morbidity and blindness. This remains a problem in developing countries. Amphotericin B (AmB) is still considered the treatment of choice for fungal infection. Liposomal formulation of AmB (L-AmB) has demonstrated promising results with higher efficacy and lower toxicity. The aim of this study is to evaluate L-AmB eye drop penetration and toxicity on the rabbit eye. Seven New Zealand rabbits were divided into three groups. Six rabbits were used for the pharmacokinetic and toxicological studies (three rabbits treatment used L-AmB 0,15%, three rabbits treatment used L-AmB 0,5%) and one served as normal control. All treatment used two concentrations of L-AmB (0.15% and 0.5%) given as eye drops every hour for three days. The pharmacokinetic study measured AmB concentration in the tissues (cornea, aqueous, lens, vitreous, sclera) using high performance liquid chromatography (HPLC), and toxic reactions were evaluated in clinical signs and histopathological examination (cornea, iris, sclera, retina). In all tissues, L-AmB 0.5% had higher concentrations of AmB than 0.15%, reached MIC in both concentrations and showed no toxic effects. Liposomes are promising drug carriers for eye diseases that can penetrate to the anterior and posterior tissues of the eye
Keyword: Liposomal Amphotericin B Eye Drops, Liposome, Drug Carrier, Keratomycosis.
DOI: https://doi.org/10.31838/ijpr/2020.12.04.261
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free